Structural and molecular determinants of CCS-mediated copper activation of MEK1/2Michael Grasso(Cancer Research Institute), Donita C. Brady(Cancer Research Institute)bioRxiv (Cold Spring Harbor Laboratory)May 2, 202010.1101/2020.05.01.072124Cited by 4SaveCiteExport RISWatch citationsRelated PapersAltered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation|Metallomics|2020|154